Detalhe da pesquisa
1.
Pharmacogenetic profile and the development of the dyskinesia induced by levodopa-therapy in Parkinson's disease patients: a population-based cohort study.
Mol Biol Rep
; 47(11): 8997-9004, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33151475
2.
Influence of DRD1 and DRD3 Polymorphisms in the Occurrence of Motor Effects in Patients with Sporadic Parkinson's Disease.
Neuromolecular Med
; 21(3): 295-302, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31119645
3.
The influence of SLC6A3 and DRD2 polymorphisms on levodopa-therapy in patients with sporadic Parkinson's disease.
J Pharm Pharmacol
; 71(2): 206-212, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30353564
4.
MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson's Disease.
J Clin Pharmacol
; 58(7): 920-926, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29578580